Paxillin and steroid signaling: From frog to human

Methods in Molecular Biology

Volumn 1204, Issue , 2014, Pages 95-108

  Hammes, Stephen R ^a   Miedlich, Susanne U ^a   Sen, Aritro ^a  

^a NONE

Author keywords

Breast cancer; Growth factors; Paxillin; Prostate cancer; Steroids

Indexed keywords

ANDROGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; GROWTH FACTOR; KI 67 ANTIGEN; PAXILLIN; PROGESTERONE RECEPTOR; STEROID; TRANSCRIPTION FACTOR EZH2; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DIVISION; CELL PROLIFERATION; CYTOPLASM; ENDOTHELIUM CELL; GENE AMPLIFICATION; GERM CELL; HUMAN; MEIOSIS; NONHUMAN; OOCYTE MATURATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; XENOPUS LAEVIS; ANIMAL; ANURA; BREAST TUMOR; CYTOLOGY; FEMALE; MALE; METABOLISM; NEOPLASM; PROSTATE TUMOR;

ANURA;

ANIMALS; ANURA; BREAST NEOPLASMS; FEMALE; GERM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEIOSIS; NEOPLASMS; PAXILLIN; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STEROIDS;

EID: 84921781674     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1346-6_9     Document Type: Article

References (57)

1. Schaller MD (2001) Paxillin: a focal adhesionassociated adaptor protein. Oncogene 20: 6459–6472
2. Turner CE (2000) Paxillin and focal adhesion signalling. Nat Cell Biol 2:E231–E236
3. Dobkin-Bekman M, Naidich M, Rahamim L et al (2009) A preformed signaling complex mediates GnRH-activated ERK phosphorylation of paxillin and FAK at focal adhesions in L beta T2 gonadotrope cells. Mol Endocrinol 23:1850–1864
4. Ishibe S, Joly D, Liu ZX, Cantley LG (2004) Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell 16:257–267
5. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM (2002) The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fi bronectin signaling. Mol Cell Biol 22:901–915
6. Ishibe S, Joly D, Zhu X, Cantley LG (2003) Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factorstimulated epithelial morphogenesis. Mol Cell 12:1275–1285
7. Guerrero-Santoro J, Yang L, Stallcup MR, DeFranco DB (2004) Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J Cell Biochem 92:810–819
8. Kasai M, Guerrero-Santoro J, Friedman R, Leman ES, Getzenberg RH, DeFranco DB (2003) The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res 63:4927–4935
9. Albertini DF, Carabatsos MJ (1998) Comparative aspects of meiotic cell cycle control in mammals. J Mol Med 76:795–799
10. Maller JL, Krebs EG (1980) Regulation of oocyte maturation. Curr Top Cell Regul 16: 271–311
11. Gill A, Jamnongjit M, Hammes SR (2004) Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol 18:97–104
12. Jamnongjit M, Gill A, Hammes SR (2005) Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation. Proc Natl Acad Sci USA 102:16257–16261
13. Lutz LB, Cole LM, Gupta MK, Kwist KW, Auchus RJ, Hammes SR (2001) Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci USA 98:13728–13733
14. Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR (2003) Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 17:1106–1116
15. Lutz LB, Kim B, Jahani D, Hammes SR (2000) G protein beta gamma subunits inhibit nongenomic progesterone-induced signaling and maturation in Xenopus laevis oocytes. Evidence for a release of inhibition mechanism for cell cycle progression. J Biol Chem 275:41512–41520
16. Sheng Y, Tiberi M, Booth RA, Ma C, Liu XJ (2001) Regulation of Xenopus oocyte meiosis arrest by G protein betagamma subunits. Curr Biol 11:405–416
17. Gallo CJ, Hand AR, Jones TL, Jaffe LA (1995) Stimulation of Xenopus oocyte maturation by inhibition of the G-protein alpha S subunit, a component of the plasma membrane and yolk platelet membranes. J Cell Biol 130:275–284
18. Deng J, Lang S, Wylie C, Hammes SR (2008) The Xenopus laevis isoform of G proteincoupled receptor 3 (GPR3) is a constitutively active cell surface receptor that participates in maintaining meiotic arrest in X. laevis oocytes. Mol Endocrinol 22:1853–1865
19. Rios-Cardona D, Ricardo-Gonzalez RR, Chawla A, Ferrell JE Jr (2008) A role for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the maintenance of meiotic arrest in Xenopus laevis oocytes. Dev Biol 317:380–388
20. Ferrell JE Jr (1999) Xenopus oocyte maturation: new lessons from a good egg. Bioessays 21:833–842
21. Gebauer F, Xu W, Cooper GM, Richter JD (1994) Translational control by cytoplasmic polyadenylation of c-mos mRNA is necessary for oocyte maturation in the mouse. EMBO J 13:5712–5720
22. Stebbins-Boaz B, Hake LE, Richter JD (1996) CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus. EMBO J 15:2582–2592
23. De Moor CH, Richter JD (1997) The Mos pathway regulates cytoplasmic polyadenylation in Xenopus oocytes. Mol Cell Biol 17:6419–6426
24. Shibuya EK, Morris J, Rapp UR, Ruderman JV (1996) Activation of the Xenopus oocyte mitogen- activated protein kinase pathway by Mos is independent of Raf. Cell Growth Differ 7:235–241
25. Mendez R, Hake LE, Andresson T, Littlepage LE, Ruderman JV, Richter JD (2000) Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 404:302–307
26. Martinez SE, Yuan L, Lacza C, Ransom H, Mahon GM, Whitehead IP, Hake LE (2005) XGef mediates early CPEB phosphorylation during Xenopus oocyte meiotic maturation. Mol Biol Cell 16:1152–1164
27. Resing KA, Mansour SJ, Hermann AS, Johnson RS, Candia JM, Fukasawa K, Vande Woude GF, Ahn NG (1995) Determination of v-Moscatalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry 34:2610–2620
28. Howard EL, Charlesworth A, Welk J, MacNicol AM (1999) The mitogen-activated protein kinase signaling pathway stimulates mos mRNA cytoplasmic polyadenylation during Xenopus oocyte maturation. Mol Cell Biol 19:1990–1999
29. Nebreda AR, Gannon JV, Hunt T (1995) Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes. EMBO J 14:5597–5607
30. Castro A, Peter M, Magnaghi-Jaulin L, Vigneron S, Galas S, Lorca T, Labbe JC (2001) Cyclin B/cdc2 induces c-Mos stability by direct phosphorylation in Xenopus oocytes. Mol Biol Cell 12:2660–2671
31. Gotoh Y, Masuyama N, Dell K, Shirakabe K, Nishida E (1995) Initiation of Xenopus oocyte maturation by activation of the mitogenactivated protein kinase cascade. J Biol Chem 270:25898–25904
32. Matten WT, Copeland TD, Ahn NG, Vande Woude GF (1996) Positive feedback between MAP kinase and Mos during Xenopus oocyte maturation. Dev Biol 179:485–492
33. Roy LM, Haccard O, Izumi T, Lattes BG, Lewellyn AL, Maller JL (1996) Mos protooncogene function during oocyte maturation in Xenopus. Oncogene 12:2203–2211
34. Liu ZX, Yu CF, Nickel C, Thomas S, Cantley LG (2002) Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association. J Biol Chem 277:10452–10458
35. Rasar M, DeFranco DB, Hammes SR (2006) Paxillin regulates steroid-triggered meiotic resumption in oocytes by enhancing an all-ornone positive feedback kinase loop. J Biol Chem 281:39455–39464
36. Sen A, Prizant H, Hammes SR (2011) Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology. Steroids 76:822–828
37. Sen A, O’Malley K, Wang Z, Raj GV, DeFranco DB, Hammes SR (2010) Paxillin regulates androgen- and epidermal growth factorinduced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 285:28787–28795
38. Auricchio F, Migliaccio A, Castoria G (2008) Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors. Steroids 73:880–884
39. Migliaccio A et al (2006) Crosstalk between EGFR and extranuclear steroid receptors. Ann N Y Acad Sci 1089:194–200
40. Hammes SR, Levin ER (2007) Extranuclear steroid receptors: nature and actions. Endocr Rev 28:726–741
41. Hammes SR, Levin ER (2011) Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489–4495
42. Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R, Hammes SR (2012) Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Inv 122:2469–2481
43. Rasar MA, Hammes SR (2006) The physiology of the Xenopus laevis ovary. Methods Mol Biol 322:17–30
44. Pearce ST, Jordan VC (2004) The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Onc Hem 50:3–22
45. Brand TM, Iida M, Li C, Wheeler DL (2011) The nuclear epidermal growth factor receptor signaling network and its role in cancer. Discov Med 12:419–432
46. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684–1691
47. Li Y, Wang JP, Santen RJ, Kim TH, Park H, Fan P, Yue W (2010) Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology 151:5146–5156
48. Williams C, Lin CY (2013) Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. E Cancer Med Sci 7:370–378
49. Levin ER (2011) Minireview: extranuclear steroid receptors—roles in modulation of cell functions. Mol Endocrinol 25:377–384
50. Razandi M, Pedram A, Rosen EM, Levin ER (2004) BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24:5900–5913
51. Reddy KB, Glaros S (2007) Inhibition of the MAP kinase activity suppresses estrogeninduced breast tumor growth both in vitro and in vivo. Int J Oncol 30:971–975
52. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplifi cation of the HER-2/neu oncogene. Science 235:177–182
53. Short SM, Yoder BJ, Tarr SM et al (2007) The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study. Breast J 12: 130–139
54. Vadlamudi R, Adam L, Tseng B, Costa L, Kumar R (1999) Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells. Cancer Res 59:2843–2846
55. Deakin NO, Turner CE (2011) Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell 22:327–341
56. Chen J, Gallo KA (2012) MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. Cancer Res 72: 4130–4140
57. Panousis D, Xepapadakis G, Lagoudianakis E et al (2013) Prognostic value of EZH2, paxillin expression and DNA ploidy of breast adenocarcinoma: correlation to pathologic predictors. J BUON 18:879–885